FLAMIN-GO: A Two-Level International Dissemination Strategy Bridging Europe and Australia
The FLAMIN-GO project implemented a two-level dissemination strategy to ensure broad visib…
FLAMIN-GO
From pathobiology to synovia on chip: driving rheumatoid arthritis to the precision medicine goal
WELCOME
FLAMIN-GO’s Vision
FLAMIN-GO’s VISION is to provide an organ-on-chip solution to open up a new avenue towards personalized care in RA. This solution will be based on the design and fabrication a multi-compartment microfluidic platform, for 3D culturing and perfusion, of all the disease-relevant joint tissues, focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system (vessels and leukocytes) who sustain the disease, as well as cartilage and bone which are the end damaged tissues, leading to permanent disability. The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.
Rheumatoid Arthritis? Chip it!
News
Workshop: Micro and Nanofabrication Technology for Next-Generation Organ-on-Chip (OoC)”
Caglari 1st October 2025 This workshop organized by CNR NANOTEC and ARCA took place in the beautiful…
Join the Innovation Dialogue Session: FORCE REPAIR – FLAMIN-GO
Two advanced EU-funded projects come together to explore how biomedical research can evolve into cli…
6th FLAMIN-GO Progress Meeting in Cagliari: Project nears the finish line with major integration milestones
The vibrant city of Cagliari, known for its sun, sea, and flocks of pink flamingos, became the symbo…
Annalisa is attending the Immunology2025 at Honolulu!
Honolulu, May 6, 2025 — Prof. Annalisa Chiocchetti is participating in Immunology2025, the world’s …
Workshop “Regulatory aspects on Organ on Chip (OoC)”
Riga, 20th November 2024 The regulatory workshop Regulatory Workshop on Organ-on-a-Chip led by Joan …
Personalized
Organ-on-chip, a multi-compartment microfluidic platform offering tailoring and personalized treatment solutions.
Targeted
Focusing on synovia and synovial fluid, which are the pathogenetic targeted tissues, but including immune system who sustain the disease, as well as cartilage and bone
Monitoring
The integration with a lab-on-chip and several sensors will allow to monitor continuously culturing conditions and response to drugs.